The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Cancer nanotechnology: application of nanotechnology in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Structure-Assigned Optical Spectra of Single-Walled Carbon Nanotubes
Bachilo, S. M., Strano, M. S., Kittrell, C., Hauge, R. H., Smalley, R. E., & Weisman, R. B. (2002) · Science · doi:10.1126/science.1078727 · Cited by 3,078
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
The use of nanocrystals in biological detection
Alivisatos, P. (2004) · Nature Biotechnology · doi:10.1038/nbt927 · Cited by 3,008
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Cytotoxicity of Colloidal CdSe and CdSe/ZnS Nanoparticles
Kirchner, C., Liedl, T., Kudera, S., Pellegrino, T., Muñoz Javier, A., Gaub, H. E., Stölzle, S., Fertig, N., & Parak, W. J. (2005) · Nano Letters · doi:10.1021/nl047996m · Cited by 1,619
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
In vivo molecular and cellular imaging with quantum dots
Gao, X., Yang, L., Petros, J. A., Marshall, F. F., Simons, J. W., & Nie, S. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.003 · Cited by 1,211
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationBiomedical applications of functionalised carbon nanotubes
Bianco, A., Kostarelos, K., Partidos, C. D., & Prato, M. (2005) · Chemical Communications · doi:10.1039/b410943k · Cited by 1,086
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Bioassay of prostate-specific antigen (PSA) using microcantilevers
Wu, G., Datar, R. H., Hansen, K. M., Thundat, T., Cote, R. J., & Majumdar, A. (2001) · Nature Biotechnology · doi:10.1038/nbt0901-856 · Cited by 1,013
Nanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602479 · Cited by 565
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538
Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.062 · Cited by 530
Self-citationBiodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526
Sparreboom, A., Scripture, C. D., Trieu, V., Williams, P. J., De, T., Yang, A., Beals, B., Figg, W. D., Hawkins, M., & Desai, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2291 · Cited by 504
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Nano-oncology: drug delivery, imaging, and sensing
Portney, N. G., & Ozkan, M. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-0247-7 · Cited by 456
Nanoparticles for biomedical imaging
Nune, S. K., Gunda, P., Thallapally, P. K., Lin, Y.-Y., Laird Forrest, M., & Berkland, C. J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903229031 · Cited by 450
Nanocarriers: Promising Vehicle for Bioactive Drugs
Rawat, M., Singh, D., Saraf, S., & Saraf, S. (2006) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.29.1790 · Cited by 449
Polymer conjugates: nanosized medicines for treating cancer
Vicent, M. J., & Duncan, R. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.11.006 · Cited by 443
Advances in fluorescence imaging with quantum dot bio-probes
Pinaud, F., Michalet, X., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Iyer, G., & Weiss, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.018 · Cited by 441
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Self-citationTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Self-citationCharrois, G. J. R., & Allen, T. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.006 · Cited by 300
Chang, M., Shiau, A., Chen, Y., Chang, C., Chen, H. H., & Wu, C. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00827.x · Cited by 281
Choi, Y., Thomas, T., Kotlyar, A., Islam, M. T., & Baker, J. R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.016 · Cited by 245
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
Bharali, D. J., Khalil, M., Gurbuz, M., et al. (2009) · PubMed · Cited by 238
Ligand-based targeted therapy for cancer tissue
Das, M., Mohanty, C., & Sahoo, S. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902780166 · Cited by 230
Self-citationIntracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Misra, R., & Sahoo, S. K. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.010 · Cited by 219
Self-citationDendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application
Kobayashi, H., & Brechbiel, M. W. (2003) · Molecular Imaging · doi:10.1162/15353500200303100 · Cited by 202
Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles
Cardinal, J., Klune, J. R., Chory, E., Jeyabalan, G., Kanzius, J. S., Nalesnik, M., & Geller, D. A. (2008) · Surgery · doi:10.1016/j.surg.2008.03.036 · Cited by 201
Fenart, L., Casanova, A., Dehouck, B., Duhem, C., Slupek, S., Cecchelli, R., & Betbeder, D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35204-8 · Cited by 196
Zhang, Y., Calon, F., Zhu, C., Boado, R. J., & Pardridge, W. M. (2003) · Human Gene Therapy · doi:10.1089/10430340360464660 · Cited by 194
Nanotechnology Applications in Surgical Oncology
Singhal, S., Nie, S., & Wang, M. D. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.60.052907.094936 · Cited by 190
Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs
Parveen, S., & Sahoo, S. K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00002 · Cited by 189
Self-citationNanotechnology for cancer diagnostics: promises and challenges
Grodzinski, P., Silver, M., & Molnar, L. K. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.3.307 · Cited by 180
Leamon, C. P., Cooper, S. R., & Hardee, G. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020089t · Cited by 180
Gabizon, A., Goren, D., Cohen, R., & Barenholz, Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00261-7 · Cited by 170
Antibody-modified liposomes for cancer chemotherapy
Torchilin, V. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.1003 · Cited by 168
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
Mousa, S., Bharali, D., Khalil, M., Gurbuz, M., & Simone (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4241 · Cited by 162
Jiang, Y.-H., Emau, P., Cairns, J. S., Flanary, L., Morton, W. R., McCarthy, T. D., & Tsai, C.-C. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.207 · Cited by 160
Mohanty, C., Acharya, S., Mohanty, A. K., Dilnawaz, F., & Sahoo, S. K. (2010) · Nanomedicine · doi:10.2217/nnm.10.9 · Cited by 157
Self-citationDevelopment trends for new cancer therapeutics and vaccines
Reichert, J. M., & Wenger, J. B. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.09.003 · Cited by 143
Tunable plasmonic nanobubbles for cell theranostics
Lukianova‐Hleb, E. Y., Hanna, E. Y., Hafner, J. H., & Lapotko, D. O. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/8/085102 · Cited by 141
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
Fassas, Α., & Anagnostopoulos, Α. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500052438 · Cited by 134
Xu, H., Regino, C. A. S., Koyama, Y., Hama, Y., Gunn, A. J., Bernardo, M., Kobayashi, H., Choyke, P. L., & Brechbiel, M. W. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0701085 · Cited by 119
Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells
Jere, D., Jiang, H., Kim, Y.-K., Arote, R. B., Choi, Y., Yun, C., Cho, M., & Cho, C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.046 · Cited by 107
Targeting anti-HIV drugs to the CNS
Rao, K. S., Ghorpade, A., & Labhasetwar, V. D. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903081705 · Cited by 100
Peng, C., Yang, L., Luo, T., Lai, P., Yang, S., Lin, W., & Shieh, M. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/15/155103 · Cited by 81
Biomedical Applications of Functionalised Carbon Nanotubes
Bianco, A., Sainz, R., Li, S., Dumortier, H., Lacerda, L., Kostarelos, K., Giordani, S., & Prato, M. (2008) · Carbon materials: chemistry and physics/Carbon materials · doi:10.1007/978-1-4020-6845-4_2 · Cited by 67
Cited by
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Nanotechnology: A Revolution in Modern Industry
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28020661 · Cited by 1,098
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
Metadata
- Authors
- Misra, R., Acharya, S., & Sahoo, S. K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 15
- Issue
- 19-20
- Pages
- 842-850
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2139107535
- Cited by
- 702
- References
- 68
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.